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and effect of acute kidney injury on survival: observational 
cohort study
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Peter T Donnan,3 Merel Van Diepen2 
ABSTRACT
Study queStion
What is the predicted risk of acute kidney injury after 
orthopaedic surgery and does it affect short term and 
long term survival?
MethodS
The cohort comprised adults resident in the National 
Health Service Tayside region of Scotland who 
underwent orthopaedic surgery from 1 January 2005 to 
31 December 2011. The model was developed in 6220 
patients (two hospitals) and externally validated in 4395 
patients from a third hospital. Several preoperative 
variables were selected for candidate predictors, based 
on literature, clinical expertise, and availability in the 
orthopaedic surgery setting. The main outcomes were 
the development of any severity of acute kidney injury 
(stages 1-3) within the first postoperative week, and 90 
day, one year, and longer term survival.
Study anSwer and liMitationS
Using logistic regression analysis, independent 
predictors of acute kidney injury were older age, male 
sex, diabetes, number of prescribed drugs, lower 
estimated glomerular filtration rate, use of angiotensin 
converting enzyme inhibitors or angiotensin receptor 
blockers, and American Society of Anesthesiologists 
grade. The model’s predictive performance for 
discrimination was good (C statistic 0.74 in 
development cohort, 0.70 in validation cohort). 
Calibration was good in the development cohort and 
after recalibration in the validation cohort. Only the 
highest risks were over-predicted. Survival was worse in 
patients with acute kidney injury compared with those 
without (adjusted hazard ratio 1.53, 95% confidence 
interval 1.38 to 1.70). This was most noticeable in the 
short term (adjusted hazard ratio: 90 day 2.36, 1.94 
to 2.87) and diminished over time (90 day-one year 
1.40, 1.10 to 1.79; >1 year 1.28, 1.10 to 1.48). The model 
used routinely collected data in the orthopaedic 
surgery setting therefore some variables that could 
potentially improve predictive performance were not 
available. However, the readily available predictors 
make the model easily applicable.
what thiS Study addS
A preoperative risk prediction model consisting of 
seven predictors for acute kidney injury was 
developed, with good predictive performance in 
patients undergoing orthopaedic surgery. Survival was 
significantly poorer in patients even with mild (stage 1) 
postoperative acute kidney injury.
Funding, CoMpeting intereStS, data Sharing
SB received grants from Tenovus Tayside, Chief 
Scientist Office, and the Royal College of Physicians 
and Surgeons of Glasgow; PT receives grants from 
Novo Nordisk, GlaxoSmithKline, and the New Drugs 
Committee of the Scottish Medicines Consortium. No 
additional data are available.
Introduction
Acute kidney injury affects 1 in 5 people during hospital 
stay1  and the condition is associated with considerably 
increased mortality. Increasing evidence shows that 
even mild, transient degrees of acute kidney injury are 
associated with both increased long term mortality and 
the future development of chronic kidney disease, inde-
pendent of other factors.2-5 In addition to these adverse 
health outcomes, acute kidney injury has a major eco-
nomic impact. Increased costs result from increased 
length of hospital stay, higher number of investigations, 
admission to an intensive care unit, and renal replace-
ment therapy. The annual cost of acute kidney injury to 
the National Health Service across the United Kingdom 
(not including cases in the community) is estimated at 
between £434m ($664m; €603m) and £620m.6
Surgery is an important cause of acute kidney injury, 
but the true incidence has been difficult to establish 
owing to the lack of a universal definition. A large US 
study showed that acute kidney injury affected 1% of 
patients undergoing non-cardiac surgery. This is likely 
to be an under-estimate as the definition used for acute 
kidney injury was an increase in serum creatinine lev-
els of 176.8 µmol/L, corresponding to severe acute kid-
ney injury.7  Since the adoption of a universally 
accepted definition for acute kidney injury (Kidney 
 Disease Improving Global Outcomes criteria),8  we have 
shown using these criteria that the rates of acute kidney 
injury ranged from 6% to 12% in gastrointestinal 
WhAT IS AlReAdy knoWn on ThIS TopIC
Acute kidney injury is common in patients undergoing surgery
No externally validated preoperative risk scores are in common use for patients 
undergoing non-cardiac surgery
WhAT ThIS STudy AddS
A preoperative risk prediction model consisting of seven predictors for acute kidney 
injury was developed, with good predictive performance in patients undergoing 
orthopaedic surgery .
Survival was significantly poorer in patients with even mild (stage 1) postoperative 
acute kidney injury
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 surgery and 23% to 25% in vascular surgery.9  Several 
studies have described the risk factors for postoperative 
acute kidney injury.10-13  To guide management, guide-
lines on acute kidney injury from both the Kidney Dis-
ease Improving Global Outcomes and National Institute 
for Health and Care Excellence highlight the impor-
tance of identifying patients at high risk for developing 
acute kidney injury.8 14 Preoperative identification of 
high risk patients would allow for earlier intervention 
and optimal perioperative management thereby 
improving patient outcomes. Early identification and 
prevention of acute kidney injury is vital because once 
the condition is established, mortality is extremely high 
and the only treatment is supportive, necessitating 
renal replacement therapy in severe cases. Currently, 
however, no externally validated preoperative risk 
scores are in common usage for non-cardiac surgery.
We developed and validated a risk score to predict 
postoperative acute kidney injury in patients undergo-
ing orthopaedic surgery and thereby identify people at 
high risk before surgery. To highlight the potential 
importance of the risk score, we also examined the 
impact of acute kidney injury on both short term and 
long term survival.
Methods
Study population
We used a development cohort and validation cohort 
for the risk prediction model. The development cohort 
included all adults aged more than 18 years who under-
went orthopaedic surgical procedures (see supplemen-
tary appendix 1) at a large teaching hospital in Dundee 
(Ninewells Hospital), Scotland, or a neighbouring 
small hospital (Stracathro Hospital) from 1 January 
2005 to 31 December 2011 and who were resident or 
died in the NHS Tayside region. For external validation 
we included patients from another hospital (Perth 
Royal Infirmary) in Scotland in the validation cohort. 
From both cohorts we excluded patients with missing 
preoperative or postoperative creatinine measure-
ments and those receiving chronic renal replacement 
therapy. We combined both cohorts for the survival 
analysis. From the general register of deaths we 
extracted data on deaths until 30 June 2014.
ethical statement
We carried out anonymised record linkage according to 
the standard operating procedure of the Health Informat-
ics Centre, University of Dundee.15  The Tayside research 
ethics committee does not require submission of individ-
ual studies that follow this standard operating proce-
dure, which is Caldicott Guardian approved. Reporting 
and methods of the study adhered to the Transparent 
Reporting of a multivariable prediction model for Indi-
vidual Prognosis Or Diagnosis (TRIPOD) statement.16- 18
patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are no 
plans to involve patients in dissemination of the results.
data sources
Data were linked using the Health Informatics Centre, Uni-
versity of Dundee.15 This centre enables anonymised link-
age of health records from the population of Tayside 
(400 000), Scotland, using a unique identifying commu-
nity health index number. We linked data between the 
following datasets: Scottish morbidity record of hospital 
admissions (SMR01); laboratory results, medicines dis-
pensed by community pharmacies, Scottish index of mul-
tiple deprivation, the Scottish Care Initiative-Diabetes 
Collaboration, the Scottish renal registry, and the theatre 
system, which records information completed by the 
anaesthetist before surgery. From the operation theatre 
system we identified operations by the operation proce-
dure codes (see supplementary appendix 1). The Scottish 
morbidity record of hospital admissions provides informa-
tion on age, sex, and postcode, and admission and dis-
charge dates. From the laboratory system we obtained 
creatinine measurements. We obtained the deprivation 
category from the Scottish index of multiple deprivation, 
and the Scottish Care Initiative-Diabetes Collaboration 
provided information on diabetes type and date of diagno-
sis. Using the Scottish renal registry, we identified patients 
receiving chronic dialysis or who had undergone renal 
transplantation. The operation theatre system provided 
information on type and urgency of operation in addition 
to the American Society of Anesthesiologists grade.
outcomes
The outcome of interest for the prediction model was the 
development of any severity of acute kidney injury 
(stages 1-3) during the first postoperative week. Severity 
was defined using the Kidney Disease Improving Global 
Outcomes criteria.8 We applied these criteria, using 
serum creatinine concentration at baseline (most recent 
before surgery) as preoperative measurement and maxi-
mal serum creatinine concentration during the first 
seven postoperative days as post-measurement. To be 
classified as having postoperative acute kidney injury, 
patients must have had at least mild acute kidney injury 
(stage 1), defined as an increase in serum creatinine level 
of at least 26.4 µmol/L or a postoperative serum creati-
nine level greater than 150% of baseline serum creatinine 
measurement. Because of inaccuracies in both measure-
ment and recording of urine output, we did not apply the 
Kidney Disease Improving Global Outcomes urine ouput 
criteria for acute kidney injury to this variable.
The primary outcome for the survival analysis was 
postoperative all cause mortality. Secondary outcomes 
were short term mortality (up to 90 days after surgery), 
intermediate term mortality (up to one year after sur-
gery), and long term mortality (to end of follow-up).
Candidate predictors
Based on previous literature and guidelines, the clinical 
knowledge of the study team, and the available data, we 
selected several preoperative variables for candidate pre-
dictors of acute kidney injury.7 14  We obtained age to the 
nearest year in the year of surgery, sex from the 
 community health index register, and social deprivation 
from the Scottish index of multiple deprivation (linked to 
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postcode from the community health index register). We 
obtained information on diabetes from the Scottish Care 
Initiative-Diabetes Collaboration, a Scottish national dia-
betes registry. From dispensed prescribing data we ascer-
tained the number of dispensed prescriptions from 
community pharmacies before admission and use of 
drugs that predispose to renal impairment (non-steroidal 
anti-inflammatory drugs (NSAIDs), cyclo-oxygenase-2 
selective inhibitors, angiotensin converting enzyme 
(ACE) inhibitors, and angiotensin II receptor antago-
nists). We classified regularly prescribed drugs as none, 
one or two drugs, or three or more drugs, and we com-
bined use of ACE inhibitors or angiotensin II receptor 
antagonists into one variable as well as use of NSAIDs or 
cyclo-oxygenase-2 selective inhibitors. Owing to recent 
reports of the association between statins and acute kid-
ney injury, we examined these drugs separately.19  From 
the laboratory database we obtained baseline renal func-
tion, which was the most recent, preoperative serum cre-
atinine measurement. This could include preoperative 
samples taken during the current admission for elective 
surgery. Patients undergoing emergency surgery, how-
ever, may have acute kidney injury on admission to hos-
pital because of trauma. We therefore used the most 
recent serum creatinine concentration before admission 
for emergency patients to distinguish chronic kidney dis-
ease from preoperative acute kidney injury. The CKD-EPI 
equation was used to calculate an estimated glomerular 
filtration rate.20  We then categorised the rates as greater 
than 60, 45-59, 30-44, and less than 29. Variables used 
from the theatre system included the American Society of 
Anesthesiologists grade, which categorises patients into 
five categories: 1=normal, healthy individual; 2=mild sys-
temic disease; 3=severe systemic disease, not incapaci-
tating; 4=incapacitating systemic disease that is a threat 
to life; and 5=moribund person who is not expected to 
survive without the operation,21 and whether the opera-
tion was elective, expedited, or an emergency. As the 
emergency operations were mainly related to trauma we 
used this variable as a proxy for trauma.
Statistical analysis
For continuous variables we present the baseline charac-
teristics as means and standard deviations or medians and 
interquartile ranges, depending on distribution. We pres-
ent categorical variables as numbers and percentages.
risk prediction
We entered 11 candidate predictors (age at operation, 
sex, baseline renal function, diabetes, number of 
 prescribed drugs, treatment with ACE inhibitor or 
angiotensin receptor blocker, treatment with NSAID or 
cyclo-oxygenase-2 selective inhibitors, treatment with 
statin, urgency of operation, American Society of Anes-
thesiologists grade, and deprivation category) into a 
multivariable logistic regression analysis, with acute 
kidney injury as the dependent variable. We used 
 backward selection to identify the most important inde-
pendent predictors, and applied a conservative selec-
tion criterion of P<0.15 to limit chances of over-fitting. 
Repeating the analysis using forward selection to check 
whether this resulted in the same list of predictors, 
ensured the model’s stability. In order to calculate an 
individual patient’s risk of acute kidney injury, we first 
calculated his or her prognostic index by multiplying 
the estimated coefficients with the values of the predic-
tor variables of the patient and taking the sum of these 
multiplications and adding the intercept of the model. 
Using the prognostic index (PI) we then calculated the 
risk of acute kidney injury as exp(PI)/(1+exp(PI)).
As the apparent predictive performance (perfor-
mance in the development cohort) usually over-esti-
mates the performance in other patients, owing to 
over-fitting of the idiosyncrasies in the development 
cohort, we internally validated the model through boot-
strapping19 22 and then externally validated it in our 
 validation cohort. To assess predictive performance, 
we estimated discrimination and calibration.
Discrimination indicates how well the model can dis-
tinguish patients with the outcome from those without 
the outcome, represented by Harrell’s C statistic.23 This 
is equal to the area under the receiver operator curve in 
a logistic regression model and lies between 0.5 and 1; 
values greater than 0.7 indicate good predictive perfor-
mance and values greater than 0.8 indicate excellent 
predictive performance.
Calibration ascertains the concordance between the 
model’s predictions and observed outcomes, which we 
evaluated using a calibration plot.24  The plot displays the 
predicted risk versus the observed frequency of acute 
kidney injury in 10ths of increasing predicted risk, aug-
mented by a smoothed (lowess) regression line.25  Ideally 
the plot follows a 45° line, showing that the predicted 
risks are equal to the observed outcome frequencies. In 
addition, we assessed the difference in predicted and 
observed frequency in the total cohort, indicating the 
extent to which predictions are systematically too high or 
too low, referred to as calibration-in-the-large.24  Finally, 
we assessed the calibration slope, reflecting the slope of 
the calibration plot and ideally equal to 1. A slope less 
than 1 indicates the degree of over-fitting of the model.26
When the prediction model is not well calibrated 
externally, predictions can be recalibrated in various 
ways.27 28  We examined two methods of recalibration, 
requiring different levels of input from the new setting. 
The first method corrects for systematic over-prediction 
or under-prediction, generally caused by a difference in 
outcome incidence in the development and validation 
cohort. A correction factor, computed from the observed 
frequency of acute kidney injury and the predicted risk 
of acute kidney injury in the external cohort, is added to 
the intercept of the model.29  The second method in 
addition also corrects for over-fitting—that is, for a cali-
bration slope less than 1. For this method the intercept 
and regression coefficient of the logistic regression 
model with the prognostic index as the only predictor 
(recalibration model) are used to transform the 
 prognostic index and compute recalibrated probabili-
ties from this recalibrated prognostic index.26 Although 
the second method is more accurate for calibration 
slopes less than 1, it is also less practical as it requires 
estimating the recalibration model in the new setting, 
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instead of merely adding an easily computable correc-
tion factor to the intercept.
To assess robustness of the model we performed sev-
eral sensitivity analyses: using multiple imputation 
with fully conditional specification to impute missing 
data,30-32 relaxing the backward selection removal crite-
rion to 0.20 and restricting it to 0.10, and adding 
non-linear and interaction terms to the model.
Survival analysis
Using Kaplan-Meier plots and log rank analyses we calcu-
lated the cumulative survival of patients with compared 
with those without acute kidney injury. We used Cox 
regression analyses to calculate hazard ratios and 95% 
confidence intervals for patients with any acute kidney 
injury compared with those without acute kidney injury, 
adjusted for confounders. We selected the confounders 
age, sex, diabetes, baseline renal function, and number of 
prescribed drugs based on literature, guidelines, and clin-
ical expertise.8 14  We examined 90 day, one year, and sur-
vival until end of follow-up, where one year survival was 
conditional on surviving 90 days and long term survival 
was conditional on surviving one year.33  Additionally, we 
analysed overall survival by stage of acute kidney injury. 
We performed bootstrap analysis using the rms package 
in R.34 All other analyses were carried out in IBM SPSS 
(v21). For survival analyses we considered a P value of less 
than 0.05 to be statistically significant 
Results
We identified 15 218 orthopaedic operations, as defined 
by the included operation procedure codes in the the-
atre operation system (see supplementary appendix 1), 
between 1 January 2005 and 31 December 2011. Both 
preoperative and postoperative creatinine values were 
available for 12 530 of these operations (17.7% missing 
data). We used the first operation for each patient and 
excluded subsequent operations in the same individ-
ual, leaving 10 615 patients in the analysis (6220 in the 
development cohort and 4395 in the validation cohort).
Baseline characteristics
Table 1 shows the baseline characteristics of the two 
cohorts. Mean age was similar between both (70.7 (SD 15.3) 
in the development cohort, 71.0 (12.3) in the validation 
cohort). Baseline estimated glomerular filtration rate was 
also similar between the groups (71 (SD 23) mL/min in the 
development cohort, 72 (20) mL/min) in the validation 
cohort). Postoperative acute kidney injury occurred in 672 
(10.8%) of the patients in the development cohort and 295 
(6.7%) in the validation cohort. Emergency surgery 
occurred most in the development cohort (28% v 13%).
predictive variables for acute kidney injury
Logistic regression with backward selection resulted in 
the final model with seven predictors: age at operation, 
male sex, diabetes, lower estimated glomerular filtration 
rate, use of ACE inhibitors or angiotensin receptor block-
ers, number of prescribed drugs and American Society of 
Anesthesiologists grade. Table 2 presents the estimates. 
Forward selection led to the same results. Sensitivity 
analyses also showed robustness of the model. Using 
multiple imputation for missing American Society of 
Anesthesiologists grade and deprivation category (926 
(14.9%) missing American Society of Anesthesiologists 
grade, 80 (13%) missing Scottish index of multiple depri-
vation category made no difference to the variables in the 
model and resulted in similar discrimination (C statistic 
0.74, 95% confidence interval 0.73 to 0.75)). Relaxation 
and restriction of the removal criterion for backward 
selection to P<0.20 and P<0.10, respectively, did not 
change the final model. Adding age as a non-linear term, 
and age, sex, diabetes, type of surgery (elective, expe-
dited, and emergency), chronic kidney disease category, 
and number of prescribed drugs as interaction terms 
with the other variables slightly altered the final predic-
tor list but did not improve the model’s performance.
Model validation
Calibration of the model was assessed by comparing 
observed to predicted risk in a calibration plot (fig 1 ). This 
plot shows, for example, that applying a cut-off of 10%, 
meaning that patients with a predicted risk higher than 
10% are classified as at high risk for acute kidney injury, 
would affect about 40% of patients. Thus this plot can 
help in deciding the cut-off above which to target inter-
ventions. From these data, the inference is that using a 
cut-off of 10%, which is about the incidence of acute kid-
ney injury in this cohort, more than 70% of acute kidney 
injury cases would be identified. Calibration was subopti-
mal in the validation cohort showing that the model 
over-predicts the risk of acute kidney injury in that cohort 
(fig 1). This was also shown by the calibration-in-the-large 
of 10.4% predicted risk compared with 6.6% observed risk 
and the calibration slope of 0.79 (table 3 ), and this could 
well be a consequence of the difference in incidence of 
acute kidney injury in each cohort. Recalibration using 
the first method improved calibration considerably (fig 2), 
resulting in a calibration-in-the-large of 6.8% compared 
with 6.6% (table 3). The second recalibration method 
using the full recalibration model to recalibrate prognos-
tic indices (slope 0.79, intercept −0.93) resulted in a 
slightly better calibration-in-the-large than using the first 
method (6.6% v 6.6%) and a slope of 1 (by definition) (fig 
2 and table 3). These results show that the difference 
between method 1 and method 2 in this case mainly stems 
from the highest 10th of predicted risk. After recalibration 
there was still some over-prediction at the highest end of 
the spectrum, but this would not further affect clinical 
decision making as these patients were already at high 
risk. We examined discrimination by calculating the C 
statistic using the receiver operator curve. The C statistic 
of the model was 0.74 (95% confidence interval 0.72 to 
0.76), indicating reasonably good predictive  performance. 
Performance was only slightly less in both the internal 
(0.73) and the external validation (0.70), indicating good 
external validity of the model (table 3). For further insight 
into the predictive value of the model, we assessed the 
incidence of acute kidney injury across 5% risk groups. 
Results in the validation cohort again showed that the 
model over-predicts the actual incidence of acute kidney 
injury, hence the need for recalibration (table 4).
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Survival
A total of 3166 (30%) out of 10 615 patients died over a 
median follow-up of 4.58 years (interquartile range 2.93-
6.69 years). Figure 3  shows the Kaplan-Meier plot of 
cumulative survival in patients with acute kidney injury 
compared with those without acute kidney injury. Fifty 
one (0.5%) out of the 10 615 patients died within seven 
days without developing acute kidney injury. Overall sur-
vival in patients with acute kidney injury was worse than 
in patients without acute kidney injury (crude hazard 
ratio 2.04, 95% confidence interval 1.84 to 2.26, P<0.001; 
adjusted hazard ratio 1.53, 1.38 to 1.70, P<0.001; table 5 ). 
The effect of acute kidney injury was most noticeable in 
the short term (90 day crude hazard ratio 3.24, 95% con-
fidence interval 2.68 to 3.91, P<0.001; adjusted hazard 
ratio 2.36, 1.94 to 2.87, P<0.001) and diminished over time 
(90 day to one year crude hazard ratio 1.89, 1.49 to 2.41, 
P<0.001; adjusted hazard ratio 1.40, 1.10 to 1.79, P=0.007; 
>1 year crude hazard ratio 1.68, 1.45 to 1.94, P<0.001; 
adjusted hazard ratio 1.28, 1.10 to 1.48, P=0.001). Survival 
worsened with increasing severity of acute kidney injury 
(table 6). Nevertheless, even mild acute kidney injury 
resulted in a considerably worse overall survival 
(adjusted hazard ratio 1.46, 1.30 to 1.63, P<0.001).
discussion
We found that between 7% and 11% of patients under-
going orthopaedic surgery will experience acute kidney 
injury. In this study we developed a preoperative risk 
prediction model identifying seven predictors for post-
operative acute kidney injury in patients undergoing 
orthopaedic surgery and validated the model in an 
external cohort of patients.
The predictors in the final model were age at opera-
tion, male sex, diabetes, lower estimated glomerular 
filtration rate, use of ACE inhibitors or angiotensin 
receptor blockers, number of prescribed drugs and 
American Society of Anesthesiologists grade. The 
importance of identifying patients at high risk, thereby 
potentially intervening to avoid acute kidney injury, was 
further emphasised by the effect of acute kidney injury 
on survival. We found that both short term and long 
table 1 | Baseline characteristics of patients in the development and validation cohorts. Values are numbers (percentages) unless stated otherwise
Characteristics
development cohort (n=6220) Validation cohort (n=4395)
acute kidney injury 
(n=672, 10.8%)
no acute kidney 
injury (n=5548) overall
acute kidney injury 
(n=295, 6.7%)
no acute kidney 
injury (n=4100) overall
Mean (SD) age (years) 76.5 (11.1) 70.0 (15.6) 70.7 (15.3) 75.3 (10.2) 70.7 (12.3) 71.0 (12.3)
Men 314 (47) 1980 (36) 2294 (37) 144 (49) 1535 (37) 1679 (38)
Women 358 (53) 3568 (64) 3926 (63) 151 (51) 2565 (63) 2716 (62)
Median (interquartile range) length of hospital stay (days) 9 (5-15) 8 (5-12) 11 (5-12) 7 (4-10) 6 (5-8) 6 (5-9)
Baseline eGFR (mL/min) 61 (25) 72 (22) 71 (23) 65 (21) 72 (19) 72 (20)
Chronic kidney disease category (eGFR mL/min):
 >60 324 (48.2) 3846 (69.3) 4170 (67.0) 180 (61.0) 2963 (72.3) 3143 (71.5)
 45-59 155 (23.1) 1077 (19.4) 1232 (19.8) 62 (21.0) 788 (19.2) 850 (19.3)
 30-44 126 (18.8) 491 (8.9) 617 (9.9) 39 (30.2) 286 (7.0) 325 (7.4)
 <29 67 (10.0) 134 (2.4) 201 (3.3) 14 (4.7) 63 (1.5) 77 (1.7)
SIMD deprivation category:
 1 (most deprived) 144 (21.4) 1026 (18.5) 1170 (18.8) 20 (6.8) 279 (6.8) 299 (6.8)
 2 123 (18.3) 932 (16.8) 1055 (17.0) 50 (16.9) 471 (11.5) 521 (11.9)
 3 105 (15.6) 992 (17.9) 1097 (17.6) 57 (19.3) 761 (18.6) 818 (18.6)
 4 199 (29.6) 1671 (30.1) 1870 (30.1) 100 (33.9) 1613 (39.3) 1713 (39.0)
 5 (least deprived) 89 (13.2) 859 (15.5) 948 (15.2) 68 (23.1) 919 (22.4) 987 (22.5)
 Missing 12 (1.8) 12 (1.8) 80 (1.3) 0 57 (1.4) 57 (13.0)
No receiving NSAIDs 101 (15) 991 (17.9) 1092 (17.6) 56 (19.0) 1112 (27.1) 1168(26.6)
No receiving ACE inhibitor or angiotensin II receptor antagonist 322 (47.9) 1371 (24.7) 1693 (27.2) 157 (53.2) 1124 (27.4) 1281 (29.1)
No receiving statins 293 (43.6) 1595 (28.7) 1888 (30.4) 117 (39.7) 1138 (27.8) 1255 (28.6)
No of prescribed drugs:
 None 136 (20.2) 2090 (37.7) 2226 (35.8) 56 (19.0) 1301 (31.7) 1357 (30.9)
 1 or 2 291 (43.3) 2423 (43.7) 2714 (43.6) 133 (45.1) 1950 (47.6) 2083 (47.4)
 ≥3 245 (36.5) 1035 (18.7) 1280 (20.6) 106 (35.9) 849 (20.7) 955 (21.7)
Operation urgency:
 Elective 312 (46.4) 2576 (46.4) 2888 (46.4) 212 (71.9) 2973 (72.5) 3185(72.5)
 Expedited 174 (25.9) 1410 (25.4) 1584 (25.5) 50 (16.9) 588 (14.3) 638 (14.5)
 Emergency 186 (27.7) 1562 (28.2) 1748 (28.1) 33 (11.2) 539 (13.1) 572 (13.0)
Diabetes 146 (21.7) 524 (9.4) 670 (10.8) 50 (16.9) 371 (9.0) 421 (9.6)
ASA grade:
 1 16 (2.4) 675 (12.2) 691 (11.1) 19 (6.4) 430 (10.5) 449 (10.2)
 2 212 (31.5) 2070 (37.3) 2282 (36.7) 101 (34.2) 1810 (44.1) 1911 (43.5)
 3 374 (40.8) 1609 (29.0) 1886 (30.3) 89 (30.2) 934 (22.8) 1023 (23.3)
 4 70 (10.4) 368 (6.6) 438 (7.0) 31 (10.5) 221 (5.4) 252 (5.7)
 Missing 100 (10.4) 826 (14.9) 926 (14.9) 55 (18.6) 705 (17.2) 760 (17.3)
eGFR=estimated glomerular filtration rate; SIMD=Scottish index of multiple deprivation; NSAIDs=non-steroidal anti-inflammatory drugs; ACE=angiotensin converting enzyme; ASA=American 
Society of Anesthesiologists.
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term survival was poorer in patients with acute kidney 
injury (defined as Kidney Disease Improving Global Out-
comes stage 1 or more) after adjustment for age, sex, dia-
betes, baseline renal function, and number of prescribed 
drugs. In addition, survival was significantly poorer in 
patients with mild acute kidney injury (stage 1) com-
pared with no acute kidney injury, and that it worsened 
with increased severity of acute kidney injury.
Comparison with other studies
Few risk scores exist for patients undergoing non-car-
diac surgery. One study found blood transfusions, 
hepaticojejunostomy, and oliguria to be the strongest 
predictors for acute kidney injury after liver resection.35 
Furthermore, several risk scores are available for car-
diac surgery.36-38  Predictors in these risk scores are, 
however, generally specific to their particular special-
ties, rendering them inapplicable to an orthopaedic 
population. There is only one risk score in general sur-
gical patients, developed by Kherterpal and colleagues 
from the United States.7 These authors examined post-
operative acute kidney injury in 75 952 patients under-
going general surgery. The independent risk factors for 
postoperative acute kidney injury they found were older 
age, male sex, emergency surgery, intraperitoneal sur-
gery, diabetes mellitus necessitating oral treatment, 
diabetes mellitus necessitating insulin, active conges-
tive heart failure, ascites, hypertension, mild preopera-
tive renal insufficiency, and moderate preoperative 
renal insufficiency. Our study differs from that study in 
several ways. Firstly, the authors defined acute kidney 
injury as an increase in serum creatinine concentration 
of 176.8 µmol/L or more from the preoperative value 
over the first 30 postoperative days. Using those criteria, 
they found that acute kidney injury complicated 1% of 
their operations. In our cohorts, the rate of acute kidney 
injury was higher (around 10%) among patients 
 undergoing orthopaedic surgery because we defined 
acute kidney injury using Kidney Disease Improving 
Global Outcomes criteria, which includes an increase of 
greater than 26.4 µmol/L in serum creatinine concentra-
tion, therefore including milder forms of acute kidney 
injury. Applying the same definition as that of Kherter-
pal and colleagues to our cohort would have identified 
similar rates of acute kidney injury but we thought it 
was important to include milder forms of acute kidney 
injury because of a notable difference in survival, even 
table 2 | predictive variables for acute kidney injury on multivariable logistic regression 
analysis of development cohort
predictors β odds ratio (95% Ci) p value
Sex (female) −0.708 0.493 (0.407 to 0.596) <0.001
Age at operation (years) 0.022 1.022 (1.013 to 1.031) <0.001
Diabetes 0.427 1.532 (1.199 to 1.959) 0.001
No of prescribed drugs:
 None (reference) — — 0.94
 1 or 2 0.130 1.139 (0.889 to 1.463) 0.308
 ≥3 0.347 1.415 (1.025 to 1.953) 0.035
ACE inhibitor or angiotensin receptor blocker 0.534 1.705 (1.343 to 2.164) <0.001
Chronic kidney disease category (eGFR mL/min):
 >60 −1.417 0.242 (0.168 to 0.351) <0.001
 45-59 −1.108 0.330 (0.226 to.0483) <0.001
 30-44 −0.676 0.508 (0.434 to 0.753) 0.001
 <29 (reference) — — <0.001
ASA grade:
 1 −1.037 0.355 (0.194 to 0.647) 0.001
 2 −0.141 0.869 (0.633 to 1.192) 0.384
 3 0.014 1.014 (0.751 to 1.368) 0.929
 4 (reference) — — 0.002
ACE=angiotensin converting enzyme; ASA=American Society of Anesthesiologists.
Intercept of model was −2.385.
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with stage 1 severity. We were unable to assess how the 
authors’ model performed in our population, as we did 
not have access to several variables used in the model. 
In addition, to increase the likelihood that the cause of 
acute kidney injury was associated specifically with 
surgery, we only included acute kidney injury occurring 
within the first seven postoperative days. Furthermore, 
we validated our prediction model externally and, 
finally, risks and predictors may differ between Ameri-
can and European populations and healthcare systems.
Several studies have examined the relation between 
postoperative acute kidney injury and mortality. One 
study found that survival in a cohort of 10 518 patients 
undergoing major surgery who were admitted to a surgi-
cal intensive care unit was worse in patients with any 
acute kidney injury (as defined by Risk, Injury, Failure, 
Loss, End-stage Kidney (RIFLE) criteria) during their hos-
pital stay, proportional to its severity (adjusted hazard 
ratio 1.18 for RIFLE risk category, 1.57 for RIFLE failure cat-
egory). Acute kidney injury remained a risk factor for mor-
tality even after adjustment for age, sex, race, type of 
surgery, comorbidities, other postoperative complica-
tions, discharge facility, and length of stay.39  This study 
was limited to patients admitted to the surgical intensive 
care unit, therefore focusing on sicker patients with an 
expected poorer long term survival, whereas we included 
all patients undergoing orthopaedic surgery. More 
recently, in a cohort of more than 50 000 patients under-
going major surgery in the United States, the same 
authors found that both in-hospital and 90 day mortality 
were higher in patients with any degree of acute kidney 
injury, adjusted for age, sex, ethnicity, primary payer, 
Charlson comorbidity index score, surgery type, emer-
gent surgery status, weekend admission, estimated glo-
merular filtration rate, and all postoperative 
complications.40 Our results from a UK population are 
comparable to this US population. In addition, we also 
examined longer term follow-up, with a median follow-up 
of 4.58 years (interquartile range 2.93-6.69 years). Even 
though these observational studies adjusted for multiple 
baseline factors, it is difficult to determine if the excess 
mortality was due to the development of acute kidney 
injury; or whether sicker patients who have a higher mor-
tality risk at baseline develop acute kidney injury.
Strengths and limitations of this study
This study has several limitations. In the absence of an 
agreed definition for baseline renal function, we used 
creatinine level at hospital admission, which is the most 
table 3 | performance of prediction model in development and validation cohort
Model performance
apparent 
validation internal validation external validation
development 
cohort
development cohort 
(with bootstrapping)
Validation 
cohort
Validation cohort 
(recalibrated: 
method 1)
Validation cohort 
(recalibrated: 
method 2)
Calibration-in-the-large (%) 10.8 v 10.8* 10.8 v 10.8* 10.4 v 6.6 6.8 v 6.6 6.6 v 6.6
Calibration slope 1.00* 0.95 0.79 0.79 1.00*
Discrimination: C statistic 0.74 0.73 0.70 0.70 0.70
*Perfect values by definition.
table 4 | incidence of acute kidney injury across different risk categories in development 
and validation cohorts
predicted 
risk
development cohort Validation cohort
no of 
patients
incidence of 
acute kidney 
injury (no)
no of 
patients
incidence of acute 
kidney injury (no)
<0.05 1377 0.03 (36) 972 0.03 (32)
0.05-0.10 1795 0.07 (123 1247 0.03 (36)
0.10-0.15 951 0.14 (129) 658 0.10 (64)
0.15-0.20 481 0.19 (90) 363 0.12 (42)
0.20-0.25 292 0.25 (72) 170 0.17 (29)
>0.25 398 0.31 (122) 225 0.16 (37)
table 5 | Comparison of short term and long term survival in patients with or without 
acute kidney injury
Survival variables no (%) of deaths hazard ratio (95% Ci) p value
Overall survival (crude)
3166 (30)
2.04 (1.84 to 2.26) <0.001
Overall survival (adjusted*) 1.53 (1.38 to 1.70) <0.001
90 day (crude)
604 (5.7)
3.24 (2.68  to 3.91) <0.001
90 day (adjusted) 2.36 (1.94 to 2.87) <0.001
1 year (crude)
543 (5.4)
1.89 (1.49 to 2.41) <0.001
1 year (adjusted) 1.40 (1.10 to 1.79) 0.007
Long term (crude) (end of follow-up)
2019 (21.3)
1.67 (1.45 to 1.94) <0.001
Long term (adjusted) (end of follow-up) 1.23 (1.10 to 1.45) 0.001
*Adjusted for age, sex, diabetes, baseline renal function, and number of prescribed drugs.
table 6 | overall adjusted survival according to severity of 
acute kidney injury
Stage*
no of 
patients
no (%) of 
deaths
hazard ratio  
(95% Ci) p value
1 (mild) 826 362 (22.8) 1.46 (1.30 to 1.63) <0.001
2 100 38 (38) 2.08 (1.51 to 2.87) <0.001
3 (severe) 41 18 (43.9) 2.77 (1.74 to 4.41) <0.001
*According to Kidney Disease Improving Global Outcomes criteria.
Days to death
Cu
m
ul
at
iv
e 
su
rv
iv
al
0 1000 2000 3000 4000
0
0.2
0.4
0.6
0.8
1.0
Acute kidney injury
No acute kidney injury
Fig 3 | Kaplan Meier plot of overall survival in patients with 
acute kidney injury compared with no acute kidney injury
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readily available in clinical practice. This could lead to 
underestimation of incidence of acute kidney injury.41 
We used routinely collected datasets in our model, there-
fore we were not able to include intraoperative factors 
such as hypotension or blood loss, which may improve 
the predictive performance of the model. However, this 
allowed us to develop a risk score that identifies patients 
who are at high risk, preoperatively. An advantage of 
using routinely collected data is that with the advent of 
electronic patients’ records, this information can be used 
easily to flag patients at high risk to individual clinicians. 
We were unable to use direct data on comorbidity 
because of problems with under-reporting.42  We there-
fore used number of prescribed drugs before admission, 
which has been shown to correlate well with comorbid-
ity.43  Our risk score was constructed and validated in 
patients undergoing orthopaedic surgery and so may not 
be applicable to other types of surgery. However, the 
increasing older population, higher expectations of 
patients, and improved technology have led to increas-
ing rates of both elective and emergency orthopaedic 
operations, resulting in orthopaedic and trauma surgery 
being one of the largest surgical specialties, accounting 
for the greatest number of elective and unplanned sur-
gery in the UK and other developed countries. Further 
work is required to validate this score in other surgical 
populations. The incidence of acute kidney injury was 
significantly lower in the validation cohort. As a result, 
calibration of our initial model was poor owing to 
over-prediction of acute kidney injury. The cause of this 
difference is not clear as it cannot be explained by avail-
able patient factors, although importantly we did not 
have data on smoking status. Observed differences in 
incidence may relate to factors pertaining to practice 
within the hospital. Recalibration to the incidence of 
acute kidney injury within a particular hospital can be a 
useful means of improving a model’s predictive perfor-
mance.24 27 44 45 We have shown both a simple means of 
recalibration and a more complex method that is less 
practical to implement. In addition, our risk score uti-
lised databases from the UK, and so before this score can 
be applied to other populations, validation is required 
using databases from other geographical areas. Other 
types of databases could affect the performance of the 
model owing to availability and reliability of recorded 
variables. The predictors included in our model are likely 
to be well documented in various other types of data-
bases, especially in the (orthopaedic) surgery setting for 
which the model was developed and intended.
Other strengths of our study include the use of the Kid-
ney Disease Improving Global Outcomes definition of 
acute kidney injury, allowing the inclusion of milder 
forms. Using a creatinine based definition may have led 
to the underestimation of acute kidney injury compared 
with using urine output.46  Urine output, however, is 
poorly measured and recorded in most hospital settings 
other than intensive care units. We only included 
patients who developed acute kidney injury within the 
first seven postoperative days, thereby minimising the 
risk of including other causes of acute kidney injury. In 
contrast with many studies that examine in-hospital, 30 
day, or 90 day mortality, our median follow-up was 4.58 
years. Our study is also the first to use external validation 
of a risk score in this population. A UK report by the 
National Confidential Enquiry into Patient Outcome and 
Death (NCEPOD) found that a fifth of acute kidney injury 
cases were preventable and 50% were related to deficien-
cies in care.44  A simple validated risk score to identify 
those patients undergoing non-cardiac surgery who are 
at high risk is currently lacking. Our risk score is simple 
to implement using routinely collected data. If the inci-
dence of acute kidney injury is known to be substantially 
different from that in our development cohort, recalibrat-
ing the model to the new setting using the correction fac-
tor method29  is advisable to help avoid systematic 
under-prediction or over-prediction. If the necessary 
data are available, recalibrating the model could be con-
sidered using the recalibration model method,26 
although in our external validation the gain in predictive 
performance was marginal. To illustrate the predictions 
of the model, consider a 70 year old man with diabetes 
and a baseline estimated glomerular filtration rate of 45 
mL/min who takes three prescribed drugs in total 
(including ramipril) and is assigned an American Society 
of Anesthesiologists grade 2 (mild systemic disease). The 
model predicted a postoperative risk of 31% for acute kid-
ney injury. The risk of acute postoperative kidney disease 
in the same patient 10 years older and with an estimated 
glomerular filtration rate of only 35 mL/min would be 
47%. Appendix 2 provides details of how to calculate this 
risk. Appendix 3 shows our risk score translated into a 
Microsoft Office Excel spreadsheet, which could be fur-
ther developed into a smartphone application. This 
would be an easy way for doctors to identify patients at 
high risk during the preoperative assessment stage and 
to guide perioperative management. Interventions could 
include increased frequency of monitoring renal func-
tion, avoidance of nephrotoxins in the perioperative 
period, and optimisation of fluid balance in high risk 
patients.8 In addition, the renal team could be alerted 
before surgery to patients at very high risk. Also, this risk 
score could be used to target patients who would benefit 
the most from implementation of an intervention in the 
clinical trials setting.
Conclusions and policy implications
We have shown that acute kidney injury affects up to 
11% of patients undergoing orthopaedic surgery, with 
increased longer term mortality even associated with 
milder forms of acute kidney injury. We developed and 
externally validated a preoperative risk prediction 
model, identifying seven predictors for acute kidney 
injury in patients undergoing orthopaedic surgery. 
These predictors are translated into a simple Excel 
spreadsheet (see appendix 3). Early identification and 
prevention of acute kidney injury has the potential to 
lead to improved patient outcomes worldwide. A simple 
risk score could be a low cost method of facilitating this, 
with important long term health and financial benefits.
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acute kidney injury; Excel spreadsheet showing risk 
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